Literature DB >> 19890780

[Emergency open surgical treatment of extravasations of cytostatic agents in the upper extremity].

P Telisselis1, G Heers, B Plock, C Baier, R Neugebauer, B Füchtmeier.   

Abstract

Extravasations of cytostatic agents can create necrosis of soft tissues in the hand and forearm. The early emergency subcutaneous "wash-out" with liposuction is the treatment of choice to avoid the development of soft-tissue defects. The objective of this study was to evaluate the open surgical debridement as a possible alternative method since the liposuction device is not commonly available in every hospital. In our study 10 patients were treated for extravasations of cytostatic drugs with a high potential for necrosis by emergency open debridement. All patients were evaluated prospectively by photography and clinical examination. 9 patients out of ten had a primary wound healing, one displayed a wound dehiscence with pre-existing MRSA infection. Another patient developed a seroma postoperatively which was treated by puncture. The mean functional outcome was good. The Eemergency open surgical treatment is a simple, in every hospital suitable therapy to prevent soft-tissue necrosis after extravasation of cytostatic drugs. Georg Thieme Verlag KG Stuttgart New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890780     DOI: 10.1055/s-0029-1241185

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  2 in total

1.  Fat Necrosis of the Breast Following Folinic Acid Extravasation.

Authors:  M Hammon; G Dilbat; R Schulz-Wendtland
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-02       Impact factor: 2.915

Review 2.  Upper limb extravasation of cytotoxic drugs: results of the saline washout technique in children.

Authors:  Virginie Mas; Anne Laure Simon; Ana Presedo; Cindy Mallet; Brice Ilharreborde; Pascal Jehanno
Journal:  J Child Orthop       Date:  2020-06-01       Impact factor: 1.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.